Michael Kiernan to Losartan
This is a "connection" page, showing publications Michael Kiernan has written about Losartan.
Connection Strength
0.973
-
Kiernan MS, Gregory D, Sarnak MJ, Rossignol P, Massaro J, Kociol R, Zannad F, Konstam MA. Early and late effects of high- versus low-dose angiotensin receptor blockade on renal function and outcomes in patients with chronic heart failure. JACC Heart Fail. 2015 Mar; 3(3):214-23.
Score: 0.470
-
Kiernan MS, Wentworth D, Francis G, Martinez FA, Dickstein K, Komajda M, Zannad F, Neaton JD, Konstam MA. Predicting adverse events during angiotensin receptor blocker treatment in heart failure: results from the HEAAL trial. Eur J Heart Fail. 2012 Dec; 14(12):1401-9.
Score: 0.402
-
Ferreira JP, Zannad F, Kiernan MS, Konstam MA. High- versus low-dose losartan and uric acid: An analysis from HEAAL. J Cardiol. 2023 07; 82(1):57-61.
Score: 0.051
-
Ferreira JP, Konstam M, Rossignol P, Kiernan MS, Zannad F. High- Versus Low-dose Losartan and Serum Potassium: An Analysis From HEAAL. J Card Fail. 2023 01; 29(1):45-52.
Score: 0.050